These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25409408)

  • 1. [Renal sympathetic denervation: still to follow after Symplicity HTN-3? No].
    Philipp T; Mitchell A; Philipp S
    Dtsch Med Wochenschr; 2014 Nov; 139(48):2467. PubMed ID: 25409408
    [No Abstract]   [Full Text] [Related]  

  • 2. [Renal sympathetic denervation: still to follow after Symplicity HTN-3? Yes].
    Mahfoud F
    Dtsch Med Wochenschr; 2014 Nov; 139(48):2466. PubMed ID: 25409407
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal denervation and Symplicity HTN-3: "Dubium sapientiae initium" (doubt is the beginning of wisdom).
    Papademetriou V; Tsioufis C; Doumas M
    Circ Res; 2014 Jul; 115(2):211-4. PubMed ID: 24989489
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
    Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
    Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous renal sympathetic denervation: 2013 and beyond.
    Froeschl M; Hadziomerovic A; Ruzicka M
    Can J Cardiol; 2014 Jan; 30(1):64-74. PubMed ID: 24365191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of Blood Pressure Following After Renal Artery Adventitia Stripping During Total Nephroureterectomy: Potential Effect of Renal Sympathetic Denervation.
    Okamura K; Satou S; Setojima K; Shono S; Miyajima S; Ishii T; Shirai K; Urata H
    Am J Case Rep; 2018 May; 19():567-572. PubMed ID: 29765015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From SYMPLICITY HTN-3 to the renal denervation global registry: where do we stand and where should we go?
    Pathak A; Ewen S; Fajadet J; Honton B; Mahfoud F; Marco J; Schlaich M; Schmieder R; Tsioufis K; Ukena C; Zeller T
    EuroIntervention; 2014 May; 10(1):21-3. PubMed ID: 24832632
    [No Abstract]   [Full Text] [Related]  

  • 9. [New opportunities of renal denervation].
    Agaeva RA; Danilov NM; Shelkova GV; Matchin YG; Chazova IE
    Ter Arkh; 2020 Jul; 92(6):84-88. PubMed ID: 33346499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension　- Insights From the SYMPLICITY HTN-3 Trial.
    Kario K; Bhatt DL; Kandzari DE; Brar S; Flack JM; Gilbert C; Oparil S; Robbins M; Townsend RR; Bakris G
    Circ J; 2016 May; 80(6):1404-12. PubMed ID: 27118620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal artery denervation for treating refractory hypertension].
    Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
    Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Position paper on the results of Symplicity HTN-3 trial. Grupo de estudio de la hipertensión arterial resistente].
    Azpiri-López JR; Assad-Morell JL; Ponce de León-Martínez E; Monreal-Puente R; Dávila-Bortoni A; Vázquez-Díaz LA; Treviño-Frutos RJ; Barrera-Oranday F; Del Angel-Soto JG; Martínez JG; Arellano-Torres M
    Arch Cardiol Mex; 2015; 85(2):154-7. PubMed ID: 25700579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal sympathetic denervation for treatment-resistant hypertension…in moderation.
    Rocha-Singh KJ; Katholi RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1887-9. PubMed ID: 23850905
    [No Abstract]   [Full Text] [Related]  

  • 14. Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings.
    Esler M
    J Am Soc Hypertens; 2014 Aug; 8(8):593-8. PubMed ID: 25151320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal denervation 2013].
    Spinar J; Vítovec J; Spinarová L
    Vnitr Lek; 2013 Aug; 59(8):724-9. PubMed ID: 24007231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective morphometric study of the suitability of renal arteries for renal denervation according to the Symplicity HTN2 trial criteria.
    Schönherr E; Rehwald R; Nasseri P; Luger AK; Grams AE; Kerschbaum J; Rehder P; Petersen J; Glodny B
    BMJ Open; 2016 Jan; 6(1):e009351. PubMed ID: 26729385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic renal denervation: hypertension beyond SYMPLICITY.
    Barbash IM; Waksman R
    Cardiovasc Revasc Med; 2013; 14(4):229-35. PubMed ID: 23928314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.
    Persu A; Kjeldsen S; Staessen JA; Azizi M
    Curr Hypertens Rep; 2016 Jan; 18(1):6. PubMed ID: 26739586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal denervation and hypertension resistant drug treatment in patient with renal artery accessory.
    Imbalzano E; Ceravolo R; Vatrano M; Lizio G; Saitta A
    Int J Cardiol; 2014 Jan; 171(1):e8-9. PubMed ID: 24331865
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
    Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL
    Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.